APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Osteoarthritis Pain

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

Selected research

Market Structure

Global Drugs for Osteoarthritis Pain Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173894060322 December 2025194 pages

Choose your research edition.

Industry ResearchDrugs for Osteoarthritis Pain Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Osteoarthritis Pain Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Drugs for Osteoarthritis Pain Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Osteoarthritis Pain Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Osteoarthritis Pain Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.

Read the full market overview

Report Includes

This report provides an overview of the global Drugs for Osteoarthritis Pain market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs for Osteoarthritis Pain and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs for Osteoarthritis Pain revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drugs for Osteoarthritis Pain market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs for Osteoarthritis Pain Segment by Company

Pfizer

Johnson & Johnson

GlaxoSmithKline

Bayer

Eli Lilly

Novartis

Sanofi

Horizon Pharma

Abbott

Mylan

Daiichi Sankyo

TEVA

Almatica Pharma

Astellas Pharma

Tide Pharmaceutical

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Abiogen Pharma

Drugs for Osteoarthritis Pain Segment by Type

Oral

Injection

External

Drugs for Osteoarthritis Pain Segment by Application

Medical Care

Personal Care

Drugs for Osteoarthritis Pain Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Osteoarthritis Pain market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Osteoarthritis Pain and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Osteoarthritis Pain.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drugs for Osteoarthritis Pain in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Osteoarthritis Pain industry.

Chapter 3: Detailed analysis of Drugs for Osteoarthritis Pain companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Osteoarthritis Painrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Table 3. Key Players of Injection Table 4. Key Players of External Table 4. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medical Care Table 6. Key Players of Personal Care Table 7. Global Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Drugs for Osteoarthritis Pain Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Drugs for Osteoarthritis Pain Market Share by Region (2021-2026) Table 10. Global Drugs for Osteoarthritis Pain Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Drugs for Osteoarthritis Pain Market Share by Region (2027-2032) Table 12. Drugs for Osteoarthritis Pain Industry Trends Table 13. Drugs for Osteoarthritis Pain Industry Drivers Table 14. Drugs for Osteoarthritis Pain Industry Opportunities and Challenges Table 15. Drugs for Osteoarthritis Pain Industry Restraints Table 16. Global Drugs for Osteoarthritis Pain Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Drugs for Osteoarthritis Pain Revenue Market Share by Company (2021-2026) Table 18. Global Drugs for Osteoarthritis Pain Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Drugs for Osteoarthritis Pain Key Company Head Office and Area Served Table 20. Global Drugs for Osteoarthritis Pain Company, Product Type & Application Table 21. Global Drugs for Osteoarthritis Pain Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Drugs for Osteoarthritis Pain Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Drugs for Osteoarthritis Pain Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2021-2026) Table 28. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2027-2032) Table 29. Global Drugs for Osteoarthritis Pain Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Drugs for Osteoarthritis Pain Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Drugs for Osteoarthritis Pain Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2021-2026) Table 33. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2027-2032) Table 34. Pfizer Company Information Table 35. Pfizer Business Overview Table 36. Pfizer Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Pfizer Drugs for Osteoarthritis Pain Product Portfolio Table 38. Pfizer Recent Development Table 39. Johnson & Johnson Company Information Table 40. Johnson & Johnson Business Overview Table 41. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Johnson & Johnson Drugs for Osteoarthritis Pain Product Portfolio Table 43. Johnson & Johnson Recent Development Table 44. GlaxoSmithKline Company Information Table 45. GlaxoSmithKline Business Overview Table 46. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Portfolio Table 48. GlaxoSmithKline Recent Development Table 49. Bayer Company Information Table 50. Bayer Business Overview Table 51. Bayer Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Bayer Drugs for Osteoarthritis Pain Product Portfolio Table 53. Bayer Recent Development Table 54. Eli Lilly Company Information Table 55. Eli Lilly Business Overview Table 56. Eli Lilly Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Eli Lilly Drugs for Osteoarthritis Pain Product Portfolio Table 58. Eli Lilly Recent Development Table 59. Novartis Company Information Table 60. Novartis Business Overview Table 61. Novartis Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Novartis Drugs for Osteoarthritis Pain Product Portfolio Table 63. Novartis Recent Development Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Sanofi Drugs for Osteoarthritis Pain Product Portfolio Table 68. Sanofi Recent Development Table 69. Horizon Pharma Company Information Table 70. Horizon Pharma Business Overview Table 71. Horizon Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Horizon Pharma Drugs for Osteoarthritis Pain Product Portfolio Table 73. Horizon Pharma Recent Development Table 74. Abbott Company Information Table 75. Abbott Business Overview Table 76. Abbott Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Abbott Drugs for Osteoarthritis Pain Product Portfolio Table 78. Abbott Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Mylan Drugs for Osteoarthritis Pain Product Portfolio Table 83. Mylan Recent Development Table 84. Daiichi Sankyo Company Information Table 85. Daiichi Sankyo Business Overview Table 86. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Portfolio Table 88. Daiichi Sankyo Recent Development Table 89. TEVA Company Information Table 90. TEVA Business Overview Table 91. TEVA Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. TEVA Drugs for Osteoarthritis Pain Product Portfolio Table 93. TEVA Recent Development Table 94. Almatica Pharma Company Information Table 95. Almatica Pharma Business Overview Table 96. Almatica Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Almatica Pharma Drugs for Osteoarthritis Pain Product Portfolio Table 98. Almatica Pharma Recent Development Table 99. Astellas Pharma Company Information Table 100. Astellas Pharma Business Overview Table 101. Astellas Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Astellas Pharma Drugs for Osteoarthritis Pain Product Portfolio Table 103. Astellas Pharma Recent Development Table 104. Tide Pharmaceutical Company Information Table 105. Tide Pharmaceutical Business Overview Table 106. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio Table 108. Tide Pharmaceutical Recent Development Table 109. Iroko Pharmaceuticals Company Information Table 110. Iroko Pharmaceuticals Business Overview Table 111. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Portfolio Table 113. Iroko Pharmaceuticals Recent Development Table 114. Hengrui Pharmaceutical Company Information Table 115. Hengrui Pharmaceutical Business Overview Table 116. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio Table 118. Hengrui Pharmaceutical Recent Development Table 119. Abiogen Pharma Company Information Table 120. Abiogen Pharma Business Overview Table 121. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Abiogen Pharma Drugs for Osteoarthritis Pain Product Portfolio Table 123. Abiogen Pharma Recent Development Table 124. North America Drugs for Osteoarthritis Pain Market Size by Type (2021-2026) & (US$ Million) Table 125. North America Drugs for Osteoarthritis Pain Market Size by Type (2027-2032) & (US$ Million) Table 126. North America Drugs for Osteoarthritis Pain Market Size by Application (2021-2026) & (US$ Million) Table 127. North America Drugs for Osteoarthritis Pain Market Size by Application (2027-2032) & (US$ Million) Table 128. North America Drugs for Osteoarthritis Pain Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) Table 130. North America Drugs for Osteoarthritis Pain Market Size by Country (2027-2032) Table 131. Europe Drugs for Osteoarthritis Pain Market Size by Type (2021-2026) & (US$ Million) Table 132. Europe Drugs for Osteoarthritis Pain Market Size by Type (2027-2032) & (US$ Million) Table 133. Europe Drugs for Osteoarthritis Pain Market Size by Application (2021-2026) & (US$ Million) Table 134. Europe Drugs for Osteoarthritis Pain Market Size by Application (2027-2032) & (US$ Million) Table 135. Europe Drugs for Osteoarthritis Pain Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) Table 137. Europe Drugs for Osteoarthritis Pain Market Size by Country (2027-2032) Table 138. China Drugs for Osteoarthritis Pain Market Size by Type (2021-2026) & (US$ Million) Table 139. China Drugs for Osteoarthritis Pain Market Size by Type (2027-2032) & (US$ Million) Table 140. China Drugs for Osteoarthritis Pain Market Size by Application (2021-2026) & (US$ Million) Table 141. China Drugs for Osteoarthritis Pain Market Size by Application (2027-2032) & (US$ Million) Table 142. Asia Drugs for Osteoarthritis Pain Market Size by Type (2021-2026) & (US$ Million) Table 143. Asia Drugs for Osteoarthritis Pain Market Size by Type (2027-2032) & (US$ Million) Table 144. Asia Drugs for Osteoarthritis Pain Market Size by Application (2021-2026) & (US$ Million) Table 145. Asia Drugs for Osteoarthritis Pain Market Size by Application (2027-2032) & (US$ Million) Table 146. Asia Drugs for Osteoarthritis Pain Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) Table 148. Asia Drugs for Osteoarthritis Pain Market Size by Country (2027-2032) Table 149. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2021-2026) & (US$ Million) Table 150. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2027-2032) & (US$ Million) Table 151. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) Table 155. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Drugs for Osteoarthritis Pain Product Image Figure 2. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drugs for Osteoarthritis Pain Market Share by Type: 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. External Image Figure 7. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Drugs for Osteoarthritis Pain Market Share by Application: 2025 VS 2032 Figure 9. Medical Care Image Figure 10. Personal Care Image Figure 11. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 13. Global Drugs for Osteoarthritis Pain Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Drugs for Osteoarthritis Pain Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Drugs for Osteoarthritis Pain Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drugs for Osteoarthritis Pain Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2021-2032) Figure 20. Global Drugs for Osteoarthritis Pain Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2021-2032) Figure 22. North America Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 23. North America Drugs for Osteoarthritis Pain Market Share by Type (2021-2032) Figure 24. North America Drugs for Osteoarthritis Pain Market Share by Application (2021-2032) Figure 25. North America Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 26. United States Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 27. Canada Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 29. Europe Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 30. Europe Drugs for Osteoarthritis Pain Market Share by Type (2021-2032) Figure 31. Europe Drugs for Osteoarthritis Pain Market Share by Application (2021-2032) Figure 32. Europe Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 33. Germany Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 34. France Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 36. Italy Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 37. Russia Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 39. China Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 40. China Drugs for Osteoarthritis Pain Market Share by Type (2021-2032) Figure 41. China Drugs for Osteoarthritis Pain Market Share by Application (2021-2032) Figure 42. Asia Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 43. Asia Drugs for Osteoarthritis Pain Market Share by Type (2021-2032) Figure 44. Asia Drugs for Osteoarthritis Pain Market Share by Application (2021-2032) Figure 45. Asia Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 46. Japan Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 50. India Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 51. Australia Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 56. Brazil Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 61. UAE Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 63. Chile Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
  • External
Applications
  • Medical Care
  • Personal Care
Companies covered
  • Pfizer
  • Johnson & Johnson
  • GlaxoSmithKline
  • Bayer
  • Eli Lilly
  • Novartis
  • Sanofi
  • Horizon Pharma
  • Abbott
  • Mylan
  • Daiichi Sankyo
  • TEVA
  • Almatica Pharma
  • Astellas Pharma
  • Tide Pharmaceutical
  • Iroko Pharmaceuticals
  • Hengrui Pharmaceutical
  • Abiogen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.2.4 External
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Medical Care
  10. 1.3.3 Personal Care
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Drugs for Osteoarthritis Pain Growth Trends by Region
  13. 1.5.1 Global Drugs for Osteoarthritis Pain Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Drugs for Osteoarthritis Pain Market Size by Region (2021-2026)
  15. 1.5.3 Drugs for Osteoarthritis Pain Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Drugs for Osteoarthritis Pain Market Dynamics
  1. 2.1 Drugs for Osteoarthritis Pain Industry Trends
  2. 2.2 Drugs for Osteoarthritis Pain Industry Drivers
  3. 2.3 Drugs for Osteoarthritis Pain Industry Opportunities and Challenges
  4. 2.4 Drugs for Osteoarthritis Pain Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drugs for Osteoarthritis Pain Revenue by Company (2021-2026)
  2. 3.2 Global Drugs for Osteoarthritis Pain Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drugs for Osteoarthritis Pain Key Company Head office and Area Served
  4. 3.4 Global Drugs for Osteoarthritis Pain Company, Product Type & Application
  5. 3.5 Global Drugs for Osteoarthritis Pain Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drugs for Osteoarthritis Pain Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drugs for Osteoarthritis Pain Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drugs for Osteoarthritis Pain Tier 1, Tier 2, and Tier 3
4 Drugs for Osteoarthritis Pain Market by Type
  1. 4.1 Global Drugs for Osteoarthritis Pain Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drugs for Osteoarthritis Pain Market Size by Type (2021-2032)
  3. 4.3 Global Drugs for Osteoarthritis Pain Market Size Share by Type (2021-2032)
5 Drugs for Osteoarthritis Pain Market by Application
  1. 5.1 Global Drugs for Osteoarthritis Pain Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drugs for Osteoarthritis Pain Market Size by Application (2021-2032)
  3. 5.3 Global Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Pfizer Drugs for Osteoarthritis Pain Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bayer Drugs for Osteoarthritis Pain Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Eli Lilly Drugs for Osteoarthritis Pain Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Drugs for Osteoarthritis Pain Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Sanofi Drugs for Osteoarthritis Pain Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
  43. 6.8 Horizon Pharma
  44. 6.8.1 Horizon Pharma Company Information
  45. 6.8.2 Horizon Pharma Business Overview
  46. 6.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Product Portfolio
  48. 6.8.5 Horizon Pharma Recent Developments
  49. 6.9 Abbott
  50. 6.9.1 Abbott Company Information
  51. 6.9.2 Abbott Business Overview
  52. 6.9.3 Abbott Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Abbott Drugs for Osteoarthritis Pain Product Portfolio
  54. 6.9.5 Abbott Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Mylan Drugs for Osteoarthritis Pain Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Daiichi Sankyo
  62. 6.11.1 Daiichi Sankyo Company Information
  63. 6.11.2 Daiichi Sankyo Business Overview
  64. 6.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Product Portfolio
  66. 6.11.5 Daiichi Sankyo Recent Developments
  67. 6.12 TEVA
  68. 6.12.1 TEVA Company Information
  69. 6.12.2 TEVA Business Overview
  70. 6.12.3 TEVA Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 TEVA Drugs for Osteoarthritis Pain Product Portfolio
  72. 6.12.5 TEVA Recent Developments
  73. 6.13 Almatica Pharma
  74. 6.13.1 Almatica Pharma Company Information
  75. 6.13.2 Almatica Pharma Business Overview
  76. 6.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Product Portfolio
  78. 6.13.5 Almatica Pharma Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 Tide Pharmaceutical
  86. 6.15.1 Tide Pharmaceutical Company Information
  87. 6.15.2 Tide Pharmaceutical Business Overview
  88. 6.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio
  90. 6.15.5 Tide Pharmaceutical Recent Developments
  91. 6.16 Iroko Pharmaceuticals
  92. 6.16.1 Iroko Pharmaceuticals Company Information
  93. 6.16.2 Iroko Pharmaceuticals Business Overview
  94. 6.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Portfolio
  96. 6.16.5 Iroko Pharmaceuticals Recent Developments
  97. 6.17 Hengrui Pharmaceutical
  98. 6.17.1 Hengrui Pharmaceutical Company Information
  99. 6.17.2 Hengrui Pharmaceutical Business Overview
  100. 6.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio
  102. 6.17.5 Hengrui Pharmaceutical Recent Developments
  103. 6.18 Abiogen Pharma
  104. 6.18.1 Abiogen Pharma Company Information
  105. 6.18.2 Abiogen Pharma Business Overview
  106. 6.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Product Portfolio
  108. 6.18.5 Abiogen Pharma Recent Developments
7 North America
  1. 7.1 North America Drugs for Osteoarthritis Pain Market Size (2021-2032)
  2. 7.2 North America Drugs for Osteoarthritis Pain Market Size by Type
  3. 7.2.1 North America Drugs for Osteoarthritis Pain Market Size by Type (2021-2026)
  4. 7.2.2 North America Drugs for Osteoarthritis Pain Market Size by Type (2027-2032)
  5. 7.2.3 North America Drugs for Osteoarthritis Pain Market Share by Type (2021-2032)
  6. 7.3 North America Drugs for Osteoarthritis Pain Market Size by Application
  7. 7.3.1 North America Drugs for Osteoarthritis Pain Market Size by Application (2021-2026)
  8. 7.3.2 North America Drugs for Osteoarthritis Pain Market Size by Application (2027-2032)
  9. 7.3.3 North America Drugs for Osteoarthritis Pain Market Share by Application (2021-2032)
  10. 7.4 North America Drugs for Osteoarthritis Pain Market Size by Country
  11. 7.4.1 North America Drugs for Osteoarthritis Pain Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  13. 7.4.3 North America Drugs for Osteoarthritis Pain Market Size by Country (2027-2032)
  14. 7.4.4 North America Drugs for Osteoarthritis Pain Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drugs for Osteoarthritis Pain Market Size (2021-2032)
  2. 8.2 Europe Drugs for Osteoarthritis Pain Market Size by Type
  3. 8.2.1 Europe Drugs for Osteoarthritis Pain Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drugs for Osteoarthritis Pain Market Share by Type (2021-2032)
  6. 8.3 Europe Drugs for Osteoarthritis Pain Market Size by Application
  7. 8.3.1 Europe Drugs for Osteoarthritis Pain Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drugs for Osteoarthritis Pain Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drugs for Osteoarthritis Pain Market Share by Application (2021-2032)
  10. 8.4 Europe Drugs for Osteoarthritis Pain Market Size by Country
  11. 8.4.1 Europe Drugs for Osteoarthritis Pain Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drugs for Osteoarthritis Pain Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drugs for Osteoarthritis Pain Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drugs for Osteoarthritis Pain Market Size (2021-2032)
  2. 9.2 China Drugs for Osteoarthritis Pain Market Size by Type
  3. 9.2.1 China Drugs for Osteoarthritis Pain Market Size by Type (2021-2026)
  4. 9.2.2 China Drugs for Osteoarthritis Pain Market Size by Type (2027-2032)
  5. 9.2.3 China Drugs for Osteoarthritis Pain Market Share by Type (2021-2032)
  6. 9.3 China Drugs for Osteoarthritis Pain Market Size by Application
  7. 9.3.1 China Drugs for Osteoarthritis Pain Market Size by Application (2021-2026)
  8. 9.3.2 China Drugs for Osteoarthritis Pain Market Size by Application (2027-2032)
  9. 9.3.3 China Drugs for Osteoarthritis Pain Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drugs for Osteoarthritis Pain Market Size (2021-2032)
  2. 10.2 Asia Drugs for Osteoarthritis Pain Market Size by Type
  3. 10.2.1 Asia Drugs for Osteoarthritis Pain Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drugs for Osteoarthritis Pain Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drugs for Osteoarthritis Pain Market Share by Type (2021-2032)
  6. 10.3 Asia Drugs for Osteoarthritis Pain Market Size by Application
  7. 10.3.1 Asia Drugs for Osteoarthritis Pain Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drugs for Osteoarthritis Pain Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drugs for Osteoarthritis Pain Market Share by Application (2021-2032)
  10. 10.4 Asia Drugs for Osteoarthritis Pain Market Size by Country
  11. 10.4.1 Asia Drugs for Osteoarthritis Pain Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drugs for Osteoarthritis Pain Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drugs for Osteoarthritis Pain Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst